Vilya
WA - SeattleBiotechnology
Focus: Vilya is a computational biology drug discovery company headquartered in Seattle, focused on ophthalmology therapeutics. The company operates at an early stage with limited publicly available scale data.
Profile data last refreshed 13h ago · AI intelligence enriched 1w ago
Total Funding
$50M
Open Jobs
1
Should You Work at Vilya?
AI assessmentEarly-stage computational biology play best suited for researchers willing to accept pre-revenue risk in exchange for platform-building opportunity.
Why Work Here
- Early-stage opportunity to shape computational biology platform in ophthalmology from the ground up
- Specialized focus on drug discovery using computational methods offers technical depth for bioinformaticians and computational chemists
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Help build intelligence for Vilya
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.